Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain.
Pardridge WM. · 2019
Read Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain. by Pardridge WM. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6966240.txt.
Introduction
Pardridge argues that brain drug development stands or falls on beating the blood-brain barrier. His review appeared in Frontiers in Aging Neuroscience. Alzheimer's disease and other brain disorders of aging need new biologic drugs, such as engineered proteins and gene therapies. Those large molecules cannot cross the barrier on their own.
The choice, he says, is binary: re-engineer the drug with delivery technology, or proceed without a delivery platform. Injecting into spinal fluid, the most common bypass, works poorly, since fluid drains fast to blood and little drug reaches deep brain tissue. Stem cells and small molecules also rarely win approval this way. Future progress, he argues, will come from delivery tools that ferry biologics across the barrier from the blood, built alongside the drugs themselves.
Catalog record
| CREATOR | Pardridge WM. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 160 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |